Effect of low-dose tadalafil once daily on glycemic control in patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, placebo-controlled pilot study

被引:0
作者
Min-Kyung Lee
Jae-Hyuk Lee
Seo-Young Sohn
Seo Yeon Lee
Tae-Yoong Jeong
Sae Chul Kim
机构
[1] Myongji Hospital,Division of Endocrinology and Metabolism, Department of Internal Medicine
[2] Hanyang University College of Medicine,Department of Urology
[3] Myongji Hospital,undefined
[4] Hanyang University College of Medicine,undefined
来源
Diabetology & Metabolic Syndrome | / 14卷
关键词
Tadalafil; Glycemic control; Erectile dysfunction; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 138 条
[11]  
Penson DF(2010)Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications Rev Endocr Metab Disord 11 61-74
[12]  
Wessells H(2017)Role of NO/VASP signaling pathway against obesity-related inflammation and insulin resistance Diabetes Metab J 41 89-95
[13]  
Zheng H(2010)Nitric oxide increases cyclic GMP levels, AMP-activated protein kinase (AMPK)alpha1-specific activity and glucose transport in human skeletal muscle Diabetologia 53 1142-1150
[14]  
Bidasee KR(2013)Nitric oxide directly promotes vascular endothelial insulin transport Diabetes 62 4030-4042
[15]  
Mayhan WG(2003)Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin Am J Physiol Endocrinol Metab 285 E123-E129
[16]  
Patel KP(2010)Systemic and metabolic effects of PDE5-inhibitor drugs World J Diabetes 1 3-7
[17]  
Ryu DS(2016)Effect of phosphodiesterase-5 inhibitors on glycemic control in person with type 2 diabetes mellitus: a systematic review and meta-analysis J Clin Transl Endocrinol 6 50-55
[18]  
Suh JK(2002)Selective phosphodiesterase type 5 inhibition using tadalafil for the treatment of erectile dysfunction Expert Opin Investig Drugs 11 1605-1613
[19]  
Francis SH(2002)Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses J Urol 168 1332-1336
[20]  
Morris GZ(2015)Therapy of endocrine disease. Effects of chronic use of phosphodiesterase inhibitors on endothelial markers in type 2 diabetes mellitus: a meta-analysis Eur J Endocrinol 172 R103-R114